O-RAY PHARMA SBIR Phase II Award, April 2020
A SBIR Phase II contract was awarded to O-Ray pharma in April, 2020 for $284,456.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like O-RAY PHARMA SBIR Phase II Award, April 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
